» Articles » PMID: 37701026

Inadequate Gastric Preparation and Its Associated Factors for Magnetically Controlled Capsule Endoscopy

Overview
Journal Front Pharmacol
Date 2023 Sep 13
PMID 37701026
Authors
Affiliations
Soon will be listed here.
Abstract

To explore factors associated with inadequate gastric preparation for MCE. Factors associated with inadequate gastric preparation for magnetically controlled capsule endoscopy (MCE) remains unclear. Data of patients who underwent MCE from June 2021 to July 2022 were prospectively collected. The gastric cleanliness score (GCS) of the six stomach regions (gastric cardia, fundus, body, angulus, antrum, and pylorus) was recorded. Patients with GCS score ≥18 were defined as the adequate preparation. Factors related to inadequate gastric preparation were analyzed using a logistic regression model with estimated odds ratios (OR). The mean GCS score of 211 patients was 17.01 ± 2.82. In the multivariable analysis, proton pump inhibitor (PPI) use (OR 3.57; 95% CI 1.69-7.95; < 0.01) and premedication time after administering simethicone <30 min (OR 2.86; 95% CI 1.10-7.39; = 0.03) were independent risk factors for inadequate gastric preparation. Comparing the gastric cleanliness of different locations, the median GCS of the lower stomach [10.00, IQR (9.50, 11.00)] was significantly higher than that of the upper stomach [7.00, IQR (6.00, 8.00)] ( <0.001). PPI use and inadequate premedication time (<30 min) may reduce the quality of gastric preparation for MCE. The type, dose, duration of medication, and discontinuation time of PPIs was well worth further exploration. Appropriate control of the type and time of premedication may be the key to improving overall gastric cleanliness.

Citing Articles

Unveiling clinicopathologic features and outcomes for endoscopic submucosal dissection of early gastric cancer at gastric angulus in China.

Wu Q, Li T, Cui Y, Jiang H, Fu Y, Jiang Q BMC Cancer. 2024; 24(1):924.

PMID: 39080615 PMC: 11290107. DOI: 10.1186/s12885-024-12610-1.

References
1.
Chang W, Yeh M, Hsu H, Chen H, Hu M . Efficacy of simethicone and N-acetylcysteine as premedication in improving visibility during upper endoscopy. J Gastroenterol Hepatol. 2013; 29(4):769-74. DOI: 10.1111/jgh.12487. View

2.
Jiang X, Qiu X, Li Z, Pan J, Peng C, Zuo X . Small-sized versus standard magnetic capsule endoscopy in adults: a two-center, double-blinded randomized controlled trial. Endoscopy. 2022; 55(1):52-57. DOI: 10.1055/a-1881-4369. View

3.
Elvas L, Areia M, Brito D, Alves S, Saraiva S, Cadime A . Premedication with simethicone and N-acetylcysteine in improving visibility during upper endoscopy: a double-blind randomized trial. Endoscopy. 2016; 49(2):139-145. DOI: 10.1055/s-0042-119034. View

4.
Takahashi Y, Amano Y, Yuki T, Ose T, Miyake T, Kushiyama Y . Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers. J Gastroenterol Hepatol. 2006; 21(11):1664-8. DOI: 10.1111/j.1440-1746.2006.04270.x. View

5.
Kim H, Hwang Y, Sung H, Jang J, Ahn C, Kim S . Effectiveness of Gastric Cancer Screening on Gastric Cancer Incidence and Mortality in a Community-Based Prospective Cohort. Cancer Res Treat. 2017; 50(2):582-589. PMC: 5912132. DOI: 10.4143/crt.2017.048. View